| Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin SL Park, A Buzzai, J Rautela, JL Hor, K Hochheiser, M Effern, N McBain, ... Nature 565 (7739), 366-371, 2019 | 324 | 2019 |
| CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours B Kruse, AC Buzzai, N Shridhar, AD Braun, S Gellert, K Knauth, J Pozniak, ... Nature 618 (7967), 1033-1040, 2023 | 81 | 2023 |
| Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens B Wylie, J Chee, CA Forbes, M Booth, SR Stone, A Buzzai, A Abad, ... Oncoimmunology, 2019 | 21 | 2019 |
| CD8+XCR1neg Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors B Wylie, J Read, AC Buzzai, T Wagner, N Troy, G Syn, SR Stone, B Foley, ... Frontiers in Immunology 9, 2990, 2019 | 14 | 2019 |
| IFNβ is a potent adjuvant for cancer vaccination strategies KM Audsley, T Wagner, C Ta, HV Newnes, AC Buzzai, SA Barnes, ... Frontiers in Immunology 12, 735133, 2021 | 13 | 2021 |
| Impaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model J Chee, C Wilson, A Buzzai, B Wylie, CA Forbes, M Booth, N Principe, ... Epigenetics 15 (1-2), 134-144, 2020 | 11 | 2020 |
| Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes AC Buzzai, T Wagner, KM Audsley, HV Newnes, LW Barrett, S Barnes, ... Frontiers in Immunology 11, 542, 2020 | 8 | 2020 |
| Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐and T‐cell acute lymphoblastic leukaemia B Foley, C Ta, S Barnes, E de Jong, M Nguyen, LC Cheung, A Buzzai, ... Clinical & Translational Immunology 9 (7), e1151, 2020 | 8 | 2020 |
| Author Correction: Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin. SL Park, A Buzzai, J Rautela, JL Hor, K Hochheiser, M Effern, N McBain, ... Nature 566 (7745), E10-E10, 2019 | 5 | 2019 |
| Tumor Immunology & Immunotherapy S Park, A Buzzai, K Hochheiser, J Rautela, JL Hor, M Effern, N McBain, ... 47th Annual Meeting of the German Society for Immunology 47, 8, 2017 | 1 | 2017 |
| Cannabinoid-1 receptors modulate acute and chronic atopic inflammation of the skin S Polkownik, K Wulff, B Kruse, AC Buzzai, S Bonifatius, E Gaffal EXPERIMENTAL DERMATOLOGY 33 (3), 2024 | | 2024 |
| Mechanisms of CD4+ T cell-mediated inflammatory cell death in melanoma K Knauth, B Kruse, AC Buzzai, S Gellert, S Bonifatius, AJ Mueller, ... EXPERIMENTAL DERMATOLOGY 33 (3), 2024 | | 2024 |
| Architecture of peripheral sensory and sympathetic neurons in Hgf-Cdk4 mouse melanomas transplanted into the skin S Gellert, AC Buzzai, O Kobler, B Kruse, S Hoehn, S Bonifatius, S Remy, ... EXPERIMENTAL DERMATOLOGY 33 (3), 2024 | | 2024 |
| 1252 Interferon mediated resistance of melanoma cells to oncolytic viruses is regulated by the melanocyte lineage transcription factor MITF S Gellert, A Buzzai, B Kruse, J Marine, F Rambow, T Tüting Journal of Investigative Dermatology 143 (5), S215, 2023 | | 2023 |
| 366 CD4+ T cells eradicate IFN-unresponsive melanomas that resist CD8+ T cell therapy B Kruse, A Buzzai, N Shridhar, A Braun, S Gellert, K Knauth, J Peters, ... Journal of Investigative Dermatology 143 (5), S63, 2023 | | 2023 |
| 012 CD4+ T cells control immune evasive tumors by reprogramming myeloid cells in an IFN-dependent manner A Buzzai, B Kruse, N Shridhar, A Braun, S Gellert, K Knauth, J Peters, ... Journal of Investigative Dermatology 143 (5), S2, 2023 | | 2023 |
| CD4+ T cell-induced inflammatory killing controls immune evasive tumours T Tüting, B Kruse, A Buzzai, N Shridhar, A Braun, S Gellert, K Knauth, ... | | 2022 |
| Intratumoral interaction dynamics of CD4+ T cells with myeloid cells during tumor regression B Kruse, A Buzzai, N Shridhar, AD Braun, T van der Sluis, K Knauth, ... EXPERIMENTAL DERMATOLOGY 31 (2), E76-E77, 2022 | | 2022 |
| Immunovirotherapy drives a convergent evolution towards interferon responsive, dedifferentiated cell states in cancer J Ruotsalainen, S Gellert, N Shridhar, K Zamecnikova, A Buzzai, J Peters, ... EXPERIMENTAL DERMATOLOGY 31 (2), E47-E48, 2022 | | 2022 |
| Impact of HCA2/Gpr109a receptor signaling on allergic inflammation in the skin S Polkownik, K Wulff, B Kruse, A Buzzai, S Bonifatius, T Tueting, E Gaffal EXPERIMENTAL DERMATOLOGY 31 (2), E61-E61, 2022 | | 2022 |
